alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Hogan Lovells US LLP is a limited liability partnership registered in the District of Columbia. “Hogan Lovells” is an international legal practice that includes Hogan Lovells US

LLP and Hogan Lovells International LLP, with offices in: Alicante Amsterdam Baltimore Beijing Brussels Caracas Colorado Springs Denver Dubai Dusseldorf

Frankfurt Hamburg Hanoi Ho Chi Minh City Hong Kong Houston Johannesburg London Los Angeles Luxembourg Madrid Miami Milan Moscow Munich New

York Northern Virginia Paris Philadelphia Prague Rio de Janeiro Rome San Francisco São Paulo Shanghai Silicon Valley Singapore Tokyo Ulaanbaatar

Warsaw Washington DC Associated offices: Budapest Jakarta Jeddah Riyadh Zagreb. For more information see www.hoganlovells.com

\\DC - 039285/000008 - 5722406 v1

Hogan Lovells US LLP

Columbia Square

555 Thirteenth Street, NW

Washington, DC 20004

T +1 202 637 5600

F +1 202 637 5910

www.hoganlovells.com

June 20, 2014

By Electronic Mail

Mr. Robert J. Finamore

Division Chief, Foreign Air Carrier Licensing

Office of International Aviation

U.S. Department of Transportation

1200 New Jersey Avenue, SE

Washington, DC 20590

Re: Application of Bahamasair Holdings Limited for Renewal and Amendment of

Exemption (Freeport, Grand Bahama Island - Baltimore/Washington /

Birmingham / Cincinnati / Columbus / Pittsburgh / Raleigh/Durham / Richmond),

Docket DOT-OST-2013-0206

Dear Mr. Finamore:

We have polled the U.S. carrier representatives served with the above-referenced application

filed on June 18, 2014, and no carrier has objected to the relief sought therein.

Sincerely,

Jonathan Echmalian

Transportation Specialist

jonathan.echmalian@hoganlovells.com

D +1 202 637 5439

cc: Docket DOT-OST-2013-0206; robert.wirick@aa.com; howard.kass@aa.com;

sascha.vanderbellen@delta.com; chris.walker@delta.com; jhill@cooley.com;

perkmann@cooley.com; bob.kneisley@wnco.com; leslie.abbott@wnco.com;

jyoung@yklaw.com; dkirstein@yklaw.com; dan.weiss@united.com;

steve.morrissey@united.com; jamie.kogutek@silverairways.com;

JCanny@amerijet.com; jrichardson@johnlrichardson.com
# C_2005248EN.01000601.xml

| 7.10.2005 | EN | Official Journal of the European Union | C 248/6 |
| --- | --- | --- | --- |

7.10.2005

EN

Official Journal of the European Union

C 248/6

---

Non-opposition to a notified concentration

(Case COMP/M.3803 — EADS/ Nokia)

(2005/C 248/05)

(Text with EEA relevance)

On 28 July 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32005M3803. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32005M3803. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---
#### Gary Don DAVIS, Appellant, v. STATE of Florida, Appellee.

No. 78-1318.

District Court of Appeal of Florida, Second District.

March 14, 1979.

Jack 0. Johnson, Public Defender, Paul C. Helm, Asst. Public Defender, and Brent A. Woolbright, Legal Intern, Bartow, for appellant.

Jim Smith, Atty. Gen., Tallahassee, and Robert J. Landry, Asst. Atty. Gen., Tampa, for appellee.

PER CURIAM.

The revocation of appellant’s probation is affirmed, but we remand for the lower court to strike the finding of violation of the condition requiring payment of court costs. Appellant did not admit this violation, and there was no evidence to show that appellant was able to pay the costs. Coxon v. *State,*365 So.2d 1067 (Fla. 2d DCA 1979).

HOBSON, A. C. J., and SCHEB and RYDER, JJ., concur.
# C_2005278EN.01001701.xml

| 11.11.2005 | EN | Official Journal of the European Union | C 278/17 |
| --- | --- | --- | --- |

11.11.2005

EN

Official Journal of the European Union

C 278/17

---

Non-opposition to a notified concentration

(Case COMP/M.3894 — Unicredito/HVB)

(2005/C 278/08)

(Text with EEA relevance)

On 18 October 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32005M3894. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32005M3894. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---
### Anomalous remanent magnetization of basalt

By: Allan Cox

                            https://doi.org/10.3133/b1083E

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
-                                 Larger Work: This publication is Chapter                                E of                                                                              Experimental and theoretical geophysics                                                                    
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
### Geology of the Maddux quadrangle, Bearpaw Mountains, Blaine County, Montana

By: Bruce BryantRobert George SchmidtWilliam Thomas Pecora

                            https://doi.org/10.3133/b1081C

#### Links

- More information:  **National Geologic Map Database Index Page**                            (html)
-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plate:  **Plate 1**                            (pdf)
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
# C_2006036EN.01002203.xml

| 11.2.2006 | EN | Official Journal of the European Union | C 36/22 |
| --- | --- | --- | --- |

11.2.2006

EN

Official Journal of the European Union

C 36/22

---

Reference for a preliminary ruling from the Supremo Tribunal de Justiça by order of that court of 3 November 2005 in Merck Genéricos-Produtos Farmacêuticos, L.da v Merck & Co. Inc and Merck Sharp & Dohme, L.da

(Case C-431/05)

(2006/C 36/46)

Language of the case: Portuguese

Reference has been made to the Court of Justice of the European Communities by order of the Supremo Tribunal de Justiça of 3 November 2005, received at the Court Registry on 5 December 2005, for a preliminary ruling in the proceedings between Merck Genéricos-Produtos Farmacêuticos, L.da and Merck & Co. Inc and Merck Sharp & Dohme, L.da on the following questions:

| 1. | Does the Court of Justice of the European Communities have jurisdiction to interpret Article 33 of the TRIPs Agreement (1)? |
| --- | --- |

1.

Does the Court of Justice of the European Communities have jurisdiction to interpret Article 33 of the TRIPs Agreement (1)?

1

| 2. | In the event of an affirmative answer to the first question, must national courts apply that article, on their own initiative or at the request of a party, in proceedings pending before them? |
| --- | --- |

2.

In the event of an affirmative answer to the first question, must national courts apply that article, on their own initiative or at the request of a party, in proceedings pending before them?

---

(1)  Agreement on trade-related aspects of intellectual property rights, Annex 1C to the World Trade Organisation Agreement, approved on behalf of the Community, with regard to matters within its competence, by Council Decision 94/800/EC of 22 December 1994 (OJ L 336, 23.12.1994 p. 1).

1

---
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 8, 2009, Cody Laboratories, 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug
ScheduleDihydromorphine (9145)
IAmphetamine (1100)
IIMethamphetamine (1105)
IIAmobarbital (2125)
IIPentobarbital (2270)
IISecobarbital (2315)
IIPhenylacetone (8501)
IICocaine (9041)
IICodeine (9050)
IIDihydrocodeine (9120)
IIOxycodone (9143)
IIHydromorphone (9150)
IIDiphenoxylate (9170)
IIEcgonine (9180)
IIHydrocodone (9193)
IIMeperidine (9230)
IIMethadone (9250)
IIMorphine (9300)
IIOxymorphone (9652)
IIAlfentanil (9737)
IIRemifentanil (9739)
IISufentanil (9740)
IIFentanyl (9801)
II
 The company plans on manufacturing the listed controlled substances in bulk for sale to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, 
                    **Federal Register**
                     Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than November 9, 2009. Dated: August 28, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. E9-21522 Filed 9-4-09; 8:45 am] BILLING CODE 4410-09-P
HomeSouth Africa

# South Africa

178 items

        -    Funding Opportunity Announcement  		FY 2021 Notice of Funding Opportunity for NGO Programs Benefiting Refuges in South Africa and Zambia	  January 26, 2021 
        -    Report  		2020 END Wildlife Trafficking Report	  October 26, 2020 
        -    Report  		2020 Investment Climate Statements: South Africa	  September 8, 2020 
        -    Report  		2020 Trafficking in Persons Report: South Africa	  June 25, 2020 
        -    Report  		Country Reports on Terrorism 2019: South Africa	  June 24, 2020 
        -    Report  		2019 Report on International Religious Freedom: South Africa	  June 10, 2020 
        -    Other Release  		FY 2020 TIP Office Initial Notification of Funding Opportunity – Program to End Modern Slavery (PEMS)	   
        -    Report  		2019 Country Reports on Human Rights Practices: South Africa	  March 11, 2020 
        -    Report  		2019 END Wildlife Trafficking Report	  November 7, 2019 
        -    TIAS  		South Africa (19-918) – Agreement on Nuclear Safety	   

previous page1…1213141516…18next page

Back to Top
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report on Form 10-Q of Merchants Bancshares, Inc. (the "Company") for the period ending March 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael R. Tuttle, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and the results of operations of the Company.  A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


| |     |                                                      
| | --- | -----------------------------------------------------
| | By: | /s/ Michael R. Tuttle                                
| |     | Michael R. Tuttle
President & Chief Executive Officer
| |     |                                                      
| |     | May 10, 2010                                         
| |     | Date
EXHIBIT 32.2






CERTIFICATION PURSUANT TO




18 U.S.C. §1350,




AS ADOPTED PURSUANT TO




SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






In connection with the Quarterly Report of BayHill Capital Corporation (the "Company") on Form 10-Q for the period ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert K. Bench, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:




1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.







Dated: November 18, 2010                                                                                 /s/  Robert K. Bench
 Robert K. Bench
 Chief Executive Officer






This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.




A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
From: Angus Crane <acrane@naima.org>

To: Susan Fairchild/RTP/USEPA/US@EPA, Keith Barnett/RTP/USEPA/US@EPA, Peter Tsirigotis/RTP/USEPA/US@EPA, Steve 

Fruh/RTP/USEPA/US@EPA

Cc: "Granta Nakayama (granta.nakayama@kirkland.com)" <granta.nakayama@kirkland.com>

Date: 06/06/2012 12:43 PM

Subject: NAIMA Letter Regarding Voluntary Policing of Chrome Emissions at "Area Sources" and Formaldehyde, Phenol, and Methanol 

Limits

Dear Ms. Fairchild:

Please find attached a letter in response to EPA’s request for an industry proposal on policing chrome emissions at 

“area sources.” This letter will be the basis of the telephone conference call scheduled for Thursday, June 7, 2012 

at 10:30 AM (Eastern). 

Sincerely, 

Angus E. Crane

Executive Vice President, General Counsel

North American Insulation Manufacturers Association

Ph: (703) 684-0084 ext. 123

Fax: (703) 684-0427

Visit NAIMA online at:

www.NAIMA.org

www.PipeInsulation.org

(See attached file: RR3317.pdf)
Exhibit 32.2



AMERICANWEST BANCORPORATION



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



I, C. Tim Cassels, state and attest that:



|(1) | I am the Chief Financial Officer of AmericanWest Bancorporation (the Registrant).
|--- | -----------------------------------------------------------------------------------



|(2) | I hereby certify, pursuant to 18 U.S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
|--- | ---------------------------------------------------------------------------------------------------------------------------------



| |  | the Quarterly Report on Form 10-Q of the Registrant for the period ended September 30, 2004 (the periodic report) containing financial statements fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78 o(d)); and
| | - | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  | the information contained in the periodic report fairly presents, in all material respects, the financial condition and results of operations of the Registrant for the periods
presented.
| | - | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|      |  |                                                     
|----- |  | ----------------------------------------------------
|Name: |  | /s/ C. Tim Cassels                                  
|Title |  | Executive Vice President and Chief Financial Officer
|Date: |  | October 28, 2004
##### 



EXHIBIT 32.1 Certification Pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Quarterly Report of First Equity Properties, Inc. (the
Company), on Form 10-Q for the period ended March 31, 2004, as filed with
Securities Exchange Commission on the date hereof (the Report), I, Ronald E.
Kimbrough, Vice President, Treasurer and Chief Accounting Officer of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:  1.
    
    The Report fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and2.
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company. Date: May 21, 2004
    /s/ Ronald E. KimbroughRonald E. KimbroughVice President, Treasurer
and Chief Accounting Officer 12
Exhibit 32.2



CERTIFICATION  PURSUANT TO THE SARBANES-OXLEY ACT

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002





I, Dr. Jean-Marie Dupuy, President & CEO of Viropro, Inc. (the Company) do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



1.  This Annual Report on 10KSB/A of the Company for the period ended November 30, 2005 as filed with the Securities and Exchange Commission (the report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.  The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.











Date: April 3, 2006.





/s/ Jean-Marie Dupuy

_______________________



Dr. Jean-Marie Dupuy

President & CEO